Position
Parallel Advisors, LLC in AbCellera Biologics Inc.
Back to the book · All holders of ABCL
Estimated mark uses implied 13F prices (value ÷ shares). Adds are treated as happening at this quarter’s mark; cuts at last quarter’s. Share jumps can be splits, not buys. This is not realized P&L.
Latest estimated mark $237$3.42 → $3.49
| Quarter | Shares | Value | Implied px | Est. mark | Flow | Weight |
|---|---|---|---|---|---|---|
| Q4 2025 | 3.4K | $11.6K | — | — | — | 0.0% |
| Q1 2026 | 3.52K | $12.3K | $3.49 | $237 | $419 | 0.0% |